News and Announcements
DJ Property rasied $300K
- Published August 08, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
DJ Property offers investors the opportunity to acquire fully paid ordinary shares in the Company. There is no minimum or maximum amount to be raised.
Key takeaways from FY17:
- raised 300K
- rated as Investment Grade by Property Investment Research
ABOUT DJ PROPERTY
DJ PROPERTY’S SENIOR EXECUTIVES HAVE EXTENSIVE EXPERIENCE IN COMMERCIAL PROPERTY AND FUNDS MANAGEMENT INDUSTRIES. TOGETHER THEY BRING A WEALTH OF KNOWLEDGE AND A NETWORK OF INDUSTRY EXPERTS ALLOWING THEM TO IDENTIFY OPPORTUNITIES.
Property is a valuable asset class that provides investors with wealth creating opportunities that are secure and protected against inflation. The DJ Property team carefully evaluates market and economic trends, qualifying opportunities through a tested process, giving investors access to thoroughly researched commercial property opportunities.
Our team has the expertise to assess your individual investment priorities and will design an investment strategy to suit your needs. We are able to source and negotiate finance on you behalf, where applicable, and also offer the legal services required to support all transactions.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
